- January 12, 2021
- Posted by: Bastion team
- Category: Markets
This post was originally published on this site
(RTTNews) – Vir Biotechnology, Inc. (VIR) and GlaxoSmithKline plc (GSK, GSK.L) announced Tuesday an agreement with the U.K.-based AGILE initiative to evaluate VIR-7832 in patients with mild to moderate COVID-19 in a Phase 1b/2a clinical trial.
The trial is due to begin in the first quarter of 2021.
VIR-7832 is a neutralizing COVID-19 antibody…
Recommended articles
- ABB sensor onboard SpaceX rocket to detect greenhouse gas emissions
An optical sensor manufactured by ABB was deployed with the successful launch of satellite Hugo from GHGSat, the emerging leader in greenhouse gas sensing services in space. QUEBEC, Jan. 24, 2021 /CN...(read more)
- Postal Workers at Gateway East Sent Home to Self-Isolate for 14 Days
OTTAWA, ON, Jan. 24, 2021 /CNW/ - On Friday, January 22, Canada Post sent afternoon shift workers from the Gateway East facility home to self-isolate for 14 days, based on the recommendations of Peel...(read more)
- Billionaire tech mogul Larry Ellison says he and Elon Musk are 'close friends.' Here are 8 other tech exec friendships that have thrived in the competitive world of Silicon Valley.
Dropbox CEO Drew Houston, left, and Mark Zuckerberg. Bill Gates and Warren Buffett. Elon Musk and Larry Ellison. Jeff Bezos and Barry Diller. What do all these high-profile pairings have in common? Th...(read more)
- Airlines have banned more than 2,500 passengers for not wearing masks – here are the carriers that have booted the most
A Delta Air Lines flight attendant. Thomas Pallini/Business InsiderMore than 2,500 passengers have been banned from US airlines for non-compliance with mask policies. Delta Air Lines banned 880 passe...(read more)
Bastion Balance Seoul, Korea.
